Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P43146 (
tumour suppressor
)
5,935
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The
tumour suppressor
EWI2
associates with tetraspanins and regulates tumour cell movement and proliferation. The short cytoplasmic domain of
EWI2
is positively charged; five out of the ten residues of this domain are basic. In the present study we demonstrated that the
EWI2
cytoplasmic tail interacts specifically with negatively charged PIPs (phosphatidylinositol phosphates), but not with other membrane lipids. The PIPs that interact with
EWI2
cytoplasmic tail include PtdIns5P, PtdIns4P, PtdIns3P, PtdIns(3,5)P(2) and PtdIns(3,4)P2. The binding affinity of PIPs to the
EWI2
tail, however, is not solely based on charge because PtdIns5P, PtdIns4P and PtdIns3P have a higher affinity to
EWI2
than PtdIns(3,5)P(2) and PtdIns(3,4)P(2) do. Mutation of either of two basic residue clusters in the
EWI2
cytoplasmic tail abolishes PIP binding, and PIP binding is also determined by the position of basic residues in the
EWI2
cytoplasmic tail. In addition,
EWI2
is constitutively palmitoylated at the cytoplasmic cysteine residues located at the N-terminal of those basic residues. The PIP interaction is not required for, but appears to regulate, the palmitoylation, whereas palmitoylation is neither required for nor regulates the PIP interaction. Functionally, the PIP interaction regulates the stability of
EWI2
proteins, whereas palmitoylation is needed for tetraspanin-
EWI2
association and
EWI2
-dependent inhibition of cell migration and lamellipodia formation. For cell-cell adhesion and cell proliferation, the PIP interaction functions in opposition to the palmitoylation. In conclusion, the
EWI2
cytoplasmic tail actively engages with the cell membrane via PIP binding and palmitoylation, which play differential roles in
EWI2
functions.
...
PMID:Differential functions of phospholipid binding and palmitoylation of tumour suppressor EWI2/PGRL. 2160 23